MedTrace Logo

Paravertebral Block Versus Erector Spinae Plane Block for Modified Radical Mastectomy in Womens.

NCT03614091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-06-26

No results posted yet for this study

Summary

postoperative pain following Modified radical mastectomy is severe specially after dissection of tissues .paravertebral plane block provides an excellent postoperative analgesia for women's,but it carry the risk of pneumothorax which it reported in some cases.Erector spinae plane block is a recent block has been mentioned in many case reports as a safe,quick and can be used in outpatient setting. we use a comparative study to compare the postoperative analgesia between both blocks and the affection of postoperative pain following both blocks if any on pulmonary functions.

Conditions

  • Pain, Postoperative
  • Pulmonary Atelectasis
  • Mastectomy

Interventions

PROCEDURE

Erector spinae plane block

20 ml Bupivacaine 0.5% below erector spinae muscle groups

PROCEDURE

Paravertebral plane block

20 ml Bupivacaine 0.5% between pleura and costotransverse ligament

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • jehan ahmed sayed, MD · Assisstant professor in Anaesthesia and ICU department,faculty of medicine,Assiut University ,egypt

  • mahmoud abdel aziz ali, PHD · Professor of Anesthesia & ICU Faculty of Medicine - Assiut University,egypt

  • mahmoud bahaa mousa, M.B.B.Ch · assisstant lecturer of Anaesthesia and ICU department,faculty of medicine ,Assiut University,egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2023-04-05
Completion
2023-12-27

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03614091 on ClinicalTrials.gov